/Investor DB

Patient Square Capital — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Kriya Therapeuticskriyatherapeutics.comin𝕏Jun 2021 · $1.2B✓ verified

Kriya Therapeutics is a biopharmaceutical company that develops and manufactures one-time gene therapies aimed at treating prevalent chronic diseases.

BiotechHealthtechMorrisville, US

Roger Jeffs(Co-Founder and Vice Chairman)inFraser Wright(Scientific Co-Founder and Chief Gene Therapy Officer)inShankar Ramaswamy(Founder)inMichele Stone(Chief Scientific Officer)inKatherine Eade(Chief Legal Officer)Britt Petty(Chief Manufacturing Officer)in

Co-investorsPremji InvestAlumni VenturesAmplo VenturesAnjostBluebird VenturesForesite Capital+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.